CKLF1-C27

Customer Review

Based on 1 Customer Validation

CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates ERK1/2 pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs. CKLF1-C27 has the potential for psoriasis research.

For research use only. We do not sell to patients.

  • Purity: 98.02%
  • CAS No.: 891861-48-6
  • Formula: C151H243N39O37
  • Molecular Weight:3196.78
  • Storage:

    Sealed storage, away from moisture and light, under nitrogen.

    Powder   -80°C, 2 years , -20°C, 1 year

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All ERK Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00